![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Nano Mobile Healthcare Inc (PK) | USOTC:VNTH | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.0001 | 50.00% | 0.0003 | 0.0002 | 0.0003 | 0.0003 | 0.0003 | 0.0003 | 4,444 | 14:39:09 |
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
____________________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): April 14, 2012
Vantage Health
(Exact name of registrant as specified in its charter)
Nevada | 333-168930 | 93-0659770 |
(State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
11400 West Olympic Boulevard, Suite 640 Los Angeles, California |
90064 |
(Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code:
(310) 477-5811
___________________________________________________ (Former name or former address, if changed since last report)
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] | Written communications pursuant to Rule 425 under the Securities Act (17CFR 230.425) |
[ ] | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
[ ] | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
[ ] | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
SECTION 1 – Registrant’s Business and Operations
Item 1.02 Termination of a Material Definitive Agreement
The information provided in Item 5.02 concerning the termination of a material definitive agreement is incorporated by reference in this Item 1.02.
SECTION 5 – Corporate Governance and Management
Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
On December 23, 2011, our company, John Harris, Peninsula Holdings Ltd., Lisa Ramakrishnan, Moxisign (PTY) Ltd., and Vantage Health Tanzania Ltd. entered into a Settlement and Resignation Agreement (the “Settlement Agreement”) pursuant to which, in part, Mr. Harris agreed to resign as CEO and director of the our company, effective April 25, 2012. Further under the Settlement Agreement the parties agreed as follows:
The foregoing description is intended only as a summary of the material terms of the Settlement Agreement and is qualified in its entirety by reference to the full Settlement Agreement, a copy of which is attached as Exhibit 10.1 to this Form 8-K and is hereby incorporated by reference herein.
SECTION 9 – Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits
Exhibit | Description |
10.1 | Settlement Agreement, dated April 14, 2012 |
2 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Vantage Health
/s/ Lisa Ramakrishnan
Lisa Ramakrishnan
President
Date: May 2, 2012
3 |
1 Year Nano Mobile Healthcare (PK) Chart |
1 Month Nano Mobile Healthcare (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions